Llwytho...
ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza
While most pathogens infect via mucosal surfaces, most current vaccines are delivered by injection. This situation remains despite awareness of the potential benefits of mucosal delivery for inducing protection against mucosa-infecting pathogens. A major obstacle to the development of such vaccines...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hum Vaccin Immunother |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514340/ https://ncbi.nlm.nih.gov/pubmed/25692970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.990859 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|